Financial Ratios | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY10802.70  +34.65 (+0.32%)
SENSEX36693.69  +99.36 (+0.27%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE1352.55-5.95 (-0.44 %)
PREV CLOSE (Rs.) 1358.50
OPEN PRICE (Rs.) 1390.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4444
TODAY'S LOW / HIGH (Rs.)1345.00 1392.00
52 WK LOW / HIGH (Rs.)419.3 1398.8
NSE1354.20-5.75 (-0.42 %)
PREV CLOSE( Rs. ) 1359.95
OPEN PRICE (Rs.) 1374.95
BID PRICE (QTY) 1354.20 (595)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40805
TODAY'S LOW / HIGH(Rs.) 1342.05 1390.00
52 WK LOW / HIGH (Rs.)421 1394

Financial Ratios

Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)38.0634.9034.2928.3831.90
   CEPS(Rs)56.1151.8950.4143.4644.71
   DPS(Rs)1.001.001.006.7513.00
   Book NAV/Share(Rs)230.45193.12167.72147.58127.25
   Tax Rate(%)31.5033.8929.4927.8722.53
Margin Ratios
   Core EBITDA Margin(%)13.5115.9914.7914.5814.58
   EBIT Margin(%)11.1812.9012.1111.6212.01
   Pre Tax Margin(%)8.399.869.017.738.43
   PAT Margin (%)5.756.526.355.576.53
   Cash Profit Margin (%)8.489.699.348.539.16
Performance Ratios
   ROA(%)6.296.387.136.5310.13
   ROE(%)17.9719.2421.6020.6532.78
   ROCE(%)17.0117.3118.5018.3323.93
   Asset Turnover(x)1.090.981.121.171.55
   Sales/Fixed Asset(x)1.661.441.641.752.19
   Working Capital/Sales(x)8.0710.9616.7019.2127.63
Efficiency Ratios
   Fixed Capital/Sales(x)0.600.700.610.570.46
   Receivable days97.4597.1089.0595.5967.25
   Inventory Days61.3670.5254.9750.6939.52
   Payable days68.0873.8267.6665.6845.51
Valuation Parameters
   PER(x)16.8314.5216.7916.0220.43
   PCE(x)11.419.7611.4210.4614.58
   Price/Book(x)2.782.623.433.085.12
   Yield(%)0.160.200.171.491.99
   EV/Net Sales(x)1.291.401.551.361.84
   EV/Core EBITDA(x)9.278.569.508.5911.69
   EV/EBIT(x)11.5310.6611.8510.7914.24
   EV/CE(x)1.381.251.551.402.02
   M Cap / Sales0.970.961.150.971.44
Growth Ratio
   Net Sales Growth(%)25.524.054.853.92118.92
   Core EBITDA Growth(%)6.984.338.163.93149.54
   EBIT Growth(%)7.174.388.890.91182.71
   PAT Growth(%)9.050.6219.03-11.04228.68
   EPS Growth(%)9.051.7920.82-11.0462.25
Financial Stability Ratios
   Total Debt/Equity(x)0.931.201.201.261.45
   Current Ratio(x)1.331.191.161.131.09
   Quick Ratio(x)0.910.740.730.770.75
   Interest Cover(x)4.014.253.902.983.36
   Total Debt/Mcap(x)0.340.460.350.410.28